Foo Chuan T, Fernando Sonali, Cohen Naomi, Adabi Golsa, Lim Cheryl M T, Young Alan C, Thien Francis
Eastern Health, Melbourne, VIC, Australia.
Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.
Asia Pac Allergy. 2020 Jul 21;10(3):e30. doi: 10.5415/apallergy.2020.10.e30. eCollection 2020 Jul.
The world's most catastrophic epidemic thunderstorm asthma event (ETSA) affected Melbourne in 2016. Little is known about the natural history of individuals affected by such extreme events.
In this single center prospective 3-year longitudinal study, symptomatology and behaviors of individuals affected by ETSA were assessed.
Standardized telephone questionnaire was used to evaluate frequency of asthma symptoms, inhaled corticosteroid preventer use, asthma action plan ownership, and healthcare utilization. Questionnaires were administered at 12, 24, and 36 months after 2016 ETSA. Subgroup analyses of the 'current', 'past', 'possible,' and 'no asthma' subgroups were also conducted.
Two hundred and eight, 164, and 112 completed questionnaires were analyzed in 2017, 2018, and 2019, respectively. Seventy to eighty five percent of respondents reported ongoing asthma symptoms in any given year, of which 20%-28% experienced weekly symptoms. Nearly 50% of respondents were prescribed preventers, with approximately 45% adherent at least 5 days a week. Less than 40% had an asthma action plan and 15%-20% sought urgent medical attention for asthma over the follow-up period. Among 106 individuals with 3 consecutive years of completed questionnaires, those with no prior doctor diagnosis of asthma were significantly more likely to be asymptomatic on follow-up than those with a prior doctor diagnosis of asthma ( = 0.02). Subgroup analyses suggest that large proportions of respondents with 'past' and 'no asthma' continue to remain symptomatic throughout the 36-month period.
In individuals affected by ETSA, we found evidence of ongoing loss of asthma control in those with previously well controlled asthma, and the persistence of symptoms suggestive of asthma in those with no history or symptoms suggestive of prior asthma, even after 36 months from initial ETSA. Low rates of inhaler adherence and asthma action plan ownership may contribute to increased morbidity and mortality from future ETSA events. Further research is required to confirm these findings.
2016年,全球最严重的灾难性流行雷暴哮喘事件(ETSA)影响了墨尔本。对于受此类极端事件影响的个体的自然病史知之甚少。
在这项单中心前瞻性3年纵向研究中,评估了受ETSA影响个体的症状和行为。
使用标准化电话问卷评估哮喘症状的频率、吸入性糖皮质激素预防剂的使用、哮喘行动计划的拥有情况以及医疗保健的利用情况。问卷在2016年ETSA后的12个月、24个月和36个月进行发放。还对“当前”“过去”“可能”和“无哮喘”亚组进行了亚组分析。
2017年、2018年和2019年分别分析了208份、164份和112份完成的问卷。70%至85%的受访者报告在任何给定年份都有持续的哮喘症状,其中20%至28%的人每周出现症状。近50%的受访者被开了预防剂,约45%的人每周至少坚持使用5天。不到40%的人有哮喘行动计划,在随访期间,15%至20%的人因哮喘寻求紧急医疗护理。在106名连续三年完成问卷的个体中,那些之前没有医生诊断为哮喘的人在随访中无症状的可能性明显高于那些之前有医生诊断为哮喘的人(P = 0.02)。亚组分析表明,很大比例的“过去”和“无哮喘”受访者在36个月期间仍有症状。
在受ETSA影响的个体中,我们发现有证据表明,以前哮喘控制良好的个体中哮喘控制持续丧失,而在没有哮喘病史或症状提示先前哮喘的个体中,即使在最初的ETSA发生36个月后,仍有提示哮喘的症状持续存在。吸入器依从性和哮喘行动计划拥有率低可能会导致未来ETSA事件的发病率和死亡率增加。需要进一步的研究来证实这些发现。